B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma

Published:2013-08 Issue:8 Volume:133 Page:2050-2058
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Wang Jinhua,Chong Kelly K.,Nakamura Yoshitaka,Nguyen Linhda,Huang Sharon K.,Kuo Christine,Zhang Wang,Yu Hua,Morton Donald L.,Hoon Dave S.B.

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference36 articles.

1. Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells;Agarwal;Carcinogenesis,2007

2. Therapeutic options in cutaneous melanoma: latest developments;Amaria;Ther Adv Med Oncol,2011

3. Clinical experiences with anti-CD137 and anti-PD1 therapeutic antibodies;Ascierto;Semin Oncol,2010

4. Final version of 2009 AJCC melanoma staging and classification;Balch;J Clin Oncol,2009

5. The chemokine system and cancer;Balkwill;J Pathol,2011

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognostic implications of cuproptosis‐related gene signature and the potential of PPIC as a promising biomarker in cutaneous melanoma;Pigment Cell & Melanoma Research;2024-08-08

2. Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies;Cancer Research Communications;2024-05-30

3. Targeting both GD2 and B7-H3 using bispecific antibody improves tumor selectivity for GD2-positive tumors;2024-05-28

4. New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3;Vaccines;2024-01-05

5. Targeting Histone 3 Variants Epigenetic Landscape and Inhibitory Immune Checkpoints: An Option for Paediatric Brain Tumours Therapy;Current Neuropharmacology;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3